TMCnet News
Webcast Alert: Trilogy Capital Partners' Inaugural Online Nanotechnology Forum to be Webcast Live Today at 12:00PM EDT LOS ANGELES --(Business Wire)-- May 7, 2004 -- Online Conference, Featuring Four Innovative Companies, to Focus on Scientific Breakthroughs in Burgeoning Nanotech IndustryTrilogy Capital Partners, Inc. is pleased to invite all investors and interested parties to attend its inaugural Online Nanotechnology Forum, to be webcast live today at 12 pm Eastern. The conference will feature four emerging growth Microcap public companies excelling in nanotechnology and related markets, as well as a keynote address by renowned nanotech entrepreneur, Scott Mize. The schedule of presenting companies is: Biophan Technologies, Inc. (OTC BB: BIPH), Isonics Corporation (NASDAQ: ISON), MFIC Corporation (OTC BB: MFIC) and Molecular Imaging Corporation (OTC BB: MLRI). "As most industry observers agree, nanotechnology is rapidly moving from the laboratory into mainstream business", commented A.J. Cervantes, president of Trilogy and forum moderator. "Investors need to be able separate, however, the companies on the cutting edge of this field, from the hype that permeates much of the market today. For those people who want to learn more about this burgeoning environment, this forum represents the opportunity to meet the senior management of four potentially high-growth companies in a convenient, 30-minute presentation. So, we invite all interested parties to join us today at www.trilogy-capital.com to learn more about these under-followed companies." -0- *T What: Biophan Technologies, Isonics Corporation, MFIC Corporation and Molecular Imaging at Trilogy Capital Partners' inaugural Online Nanotechnology Forum. Who: Conference Moderator: A.J. Cervantes, President - Trilogy Capital Partners, Inc. Keynote Speaker: Scott Mize, AngstroVision, Inc. When: Friday, May 7, 2004 12:00PM Eastern Where: Please register at www.trilogy-capital.com. Pre-registration is required. Cost: The conference is completely free of charge. How: Live over the Internet - registered attendees will receive instructions via email prior to the event. Archive: If you are unable to participate during the live webcast, the Forum will be archived for replay at www.trilogy-capital.com. *T Forum Presenters Biophan Technologies, Inc. (OTC BB: BIPH) Committed to growth through innovation and developmental leadership, Biophan and its licensors have nine issued U.S. patents and over fifty patents pending, in areas including nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com. Isonics Corporation (NASDAQ: ISON) is divided into two segments: (1) Isonics Semiconductor and (2) Isonics Life Sciences. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. For more information: www.isonics.com. MFIC Corporation (OTC BB: MFIC), through its Microfluidics Division, provides patented and proprietary, high performance Microfluidizer(R) materials processing equipment to the pharmaceutical, biotechnology, chemical, cosmetic/personal care, and food processing industries. To find out more about MFIC, visit its website at www.mficcorp.com. Molecular Imaging Corporation (OTC BB: MLRI) is a leading national service provider of Positron Emission Tomography ("PET") diagnostic imaging services. The Company operates both mobile and permanent (fixed) PET imaging technologies for hospitals, diagnostic imaging centers and physician group practices offices across the U.S. www.molecularimagingcorp.com. About Trilogy Capital Partners Trilogy Capital Partners is a Los Angeles-based financial services company engaged in merchant banking, strategic planning, financial marketing and communications. Based on the simple concept that many well-run public companies are not realizing their full value in the marketplace, Trilogy has aggregated highly experienced executives into a formidable financial and marketing team, which help investors identify and maximize prospective high-return opportunities. Trilogy is committed to identifying companies with strong management, a compelling business model and, most importantly, companies that may be seriously undervalued. For more information on Trilogy, or its portfolio clients, please visit www.trilogy-capital.com. |
